Peter Sehr
- Epidemiology top 1%
- Cervical Cancer and HPV Research 32
- Hepatitis B Virus Studies 13
- Immunology top 2%
- Immunotherapy and Immune Responses 15
- Toxin Mechanisms and Immunotoxins 5
- Virology top 2%
- Otorhinolaryngology top 2%
- Dermatology top 2%
-
- Virus-based gene therapy research 13
-
- Genital Health and Disease 5
-
- RNA and protein synthesis mechanisms 4
-
- PARP inhibition in cancer therapy 4
- Co-authors
- Michael PawlitaTim WaterboerKlaus AktoriesMartin MüllerDavid NjusGudula SchmidtMatthias WilmGeorge K. Radda
- Cited by
- EpidemiologyImmunologyVirology
- Partner nations
- GermanyFranceUnited Kingdom
In The Last Decade
Peter Sehr
76 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 133
- Epidemiology 2.5k
- Immunology 1.3k
- Virology 240
- Otorhinolaryngology 182
- Dermatology 257
Countries citing papers authored by Peter Sehr
This map shows the geographic impact of Peter Sehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sehr more than expected).
Fields of papers citing papers by Peter Sehr
This network shows the impact of papers produced by Peter Sehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sehr. The network helps show where Peter Sehr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Sehr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 18 | |
| 5 | 2022 | 9 | |
| 6 | 2021 | 23 | |
| 7 | 2021 | 38 | |
| 8 | 2020 | 15 | |
| 9 | 2020 | 34 | |
| 10 | 2019 | 66 | |
| 11 | 2018 | 115 | |
| 12 | 2014 | 41 | |
| 13 | 2013 | 64 | |
| 14 | 2008 | 69 | |
| 15 | 2008 | 29 | |
| 16 | 2007 | 11 | |
| 17 | 2006 | 30 | |
| 18 | 2005 | 25 | |
| 19 | 2004 | 30 | |
| 20 | Non-destructive measurement of metabolites and tissue pH in the kidney by 31P nuclear magnetic resonance. | 1979 | 29 |
About Peter Sehr
Peter Sehr is a scholar working on Virology, Epidemiology and Immunology, having authored 78 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (32 papers), Immunotherapy and Immune Responses (15 papers), Virus-based gene therapy research (13 papers), Hepatitis B Virus Studies (13 papers), Genital Health and Disease (5 papers), Toxin Mechanisms and Immunotoxins (5 papers), RNA and protein synthesis mechanisms (4 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Epidemiology (2.5k citations), Immunology (1.3k citations) and Virology (240 citations). Peter Sehr has collaborated with scholars based in Germany, France and United Kingdom. Frequent co-authors include Michael Pawlita, Tim Waterboer, Klaus Aktories, Martin Müller, David Njus, Gudula Schmidt, Matthias Wilm, George K. Radda, Kristina M. Michael and Robert P. Casey. Their work appears in journals such as Vaccine, Journal of Biological Chemistry, Biochemistry, PLoS ONE and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.